Let's check on the charts of IDEXX Laboratories and Zoetis.
A handful of standouts among the dozen stocks that make up the Tax-Loss Selling Recovery Portfolio pushed the group higher over the last month.
PETS has generated positive operating cash flow for more than a decade and it has been using that cash flow to pay dividends to shareholders.
The chart on Chewy is one ugly mutt, there's no denying it, but the price action turned this week.
September's wave of buying in value stocks likely helped lift some of the 12 companies that are part of the 2018 Tax-Loss Selling Recovery Portfolio.
Alexion Pharmaceuticals and Elanco Animal Health have seen their shares go to the dogs of late, but still offer reasons for portfolio consideration.
I'm more of the notion to play the run into earnings rather than through earnings.
IDEXX Laboratories and Zoetis Inc. appear ready to trade higher, offering stable opportunities as the dog-eat-dog trade war lingers on.
Here's how to play the stock right now.
The names include a veterinary drug concern plus companies with successful drugs on the market.